Where are they now? This 2003 article mentions 12 selected phenotypic screening biotech companies. Today, their average market cap is $4.7B. https://sci-hub.tw/10.1038/nbt0803-859 …
Replying to @The_Lagrangian
arithmetic mean. Half are dead; one (Vertex) is worth $44B now.
4:10 PM - 18 Jul 2019
0 replies
0 retweets
4 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.